Why the study?
What are the prescription practices concerning psychotropic drugs in an oncology population?
What are the prescription practices concerning psychotropic drugs in an oncology population?
Psychotropic drugs are frequently prescribed in oncology patients, primarily hypnotics for sleep and anti-psychotics/anti-anxiety agents for nausea/vomiting and distress, with very low rates of anti-depressant use.
Answers are grounded in this paper and cite their sources.
Frequent psychotropic prescribing in oncology warrants stewardship review; leaves open questions on appropriateness and outcomes.
The present study examined the prescription practices concerning psychotropic drugs in 5 major oncology centers over a 6 month period. During the survey period 1579 patients were admitted to the collaborating institutions, and 51% of them were prescribed at least one psychotropic medication. Hypnotics were the most frequently prescribed drugs, accounting for 48% of total prescriptions, followed by anti-psychotics at 26% and anti-anxiety agents at 25%. Anti-depressant drugs accounted for only 1% of psychotropic prescriptions. Analysis of prescription rationales revealed that 44% of the psychotropic prescriptions were written for sleep, while 25% were given for nausea and vomiting; approximately 17% were attributed to psychological distress, and 12% were associated with diagnostic medical procedures. The overall rate of prescription was approximately 2 psychotropic drugs per patient per admission, with only 2% of prescriptions resulting in chart-documented side effects. At the level of individual compounds, 3 distinct drugs accounted for 72% of total prescriptions--flurazepam (33%), prochlorperazine (21%), and diazepam (17%).
No takes yet. Share an insight, caveat, or question.
Derogatis et al. (1979) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: